These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8566149)

  • 1. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Squadrito G; Campo GM; Serranò M; Sardella A; Urna G; Spignoli G
    Eur J Pharmacol; 1995 Nov; 286(1):31-9. PubMed ID: 8566149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective thromboxane synthetase inhibition by picotamide and effects on endotoxin-induced lethality.
    Matera G; Chisari M; Altavilla D; Foca A; Cook JA
    Proc Soc Exp Biol Med; 1988 Jan; 187(1):58-61. PubMed ID: 3277192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Zingarelli B; Ioculano MP; Campo GM; Calapai G; Saitta A; Urna G; Sardella A; Spignoli G
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):115-9. PubMed ID: 1375677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of BAY U 3405, a thromboxane A2 receptor antagonist, in endotoxin shock.
    Altavilla D; Canale P; Squadrito F; Sardella A; Ammendolia L; Urna G; Ioculano M; Squadrito G; Caputi AP
    Pharmacol Res; 1994; 30(2):137-51. PubMed ID: 7816742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
    Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.
    Halushka PV; Cook JA; Wise WC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a pyridine derivative thromboxane synthetase inhibitor and its inactive isomer in endotoxic shock in the rat.
    Anderegg K; Anzeveno P; Cook JA; Halushka PV; McCarthy J; Wagner E; Wise WC
    Br J Pharmacol; 1983 Apr; 78(4):725-32. PubMed ID: 6687819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of tyrphostin AG-556 on shock induced by endotoxin or gram positive bacteria.
    Ogura S; Umegaki O; Genovese F; Fernando LP; Cochran JB; Romeo CM; Cook JA
    Shock; 1999 Aug; 12(2):105-10. PubMed ID: 10446890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the beneficial effects of aspirin in endotoxic shock. Relationship to inhibition of arachidonic acid metabolism.
    Halushka PV; Wise WC; Cook JA
    Am J Med; 1983 Jun; 74(6A):91-6. PubMed ID: 6687979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Spignoli G; Caputi AP
    Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin-induced procoagulant activity, eicosanoid synthesis, and tumor necrosis factor production by rat peritoneal macrophages: effect of endotoxin tolerance and glucan.
    Moore JN; Cook JA; Morris DD; Halushka PV; Wise WC
    Circ Shock; 1990 Jul; 31(3):281-95. PubMed ID: 2113440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia.
    Olanoff LS; Cook JA; Eller T; Knapp DR; Halushka PV
    J Cardiovasc Pharmacol; 1985; 7(1):114-20. PubMed ID: 2580129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
    Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
    Baba H
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
    Quest DW; Wilson TW
    Jpn J Pharmacol; 1998 Dec; 78(4):479-86. PubMed ID: 9920205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.
    Cook JA; Wise WC; Halushka PV
    J Clin Invest; 1980 Jan; 65(1):227-30. PubMed ID: 7350199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of nuclear factor-kappaB activation by IRFI 042, protects against endotoxin-induced shock.
    Altavilla D; Squadrito G; Minutoli L; Deodato B; Bova A; Sardella A; Seminara P; Passaniti M; Urna G; Venuti SF; Caputi AP; Squadrito F
    Cardiovasc Res; 2002 Jun; 54(3):684-93. PubMed ID: 12031715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock.
    Altavilla D; Squadrito F; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Quartarone C; Saitta A; Caputi AP
    Eur J Pharmacol; 1999 Mar; 369(1):49-55. PubMed ID: 10204681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications for thromboxane A2 in the pathogenesis of endotoxic shock.
    Wise WC; Cook JA; Halushka PV
    Adv Shock Res; 1981; 6():83-91. PubMed ID: 6961767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.